Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
229.48
+4.67 (+2.08%)
Official Closing Price
Updated: 7:00 PM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,463,195
Open
225.82
Bid (Size)
228.65 (100)
Ask (Size)
230.00 (300)
Prev. Close
224.81
Today's Range
225.79 - 231.43
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.02%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Axsome Therapeutics (AXSM): A CNS Powerhouse at a Commercial Crossroad
February 23, 2026
As of February 23, 2026, the biotechnology landscape has shifted away from the speculative fervor of the early 2020s toward a demand for commercial execution and sustainable revenue. Standing at the...
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
1 Cash-Producing Stock to Target This Week and 2 We Ignore
February 22, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...
Via
StockStory
Performance
YTD
+0.1%
+0.1%
1 Month
+3.9%
+3.9%
3 Month
-0.0%
-0.0%
6 Month
+10.6%
+10.6%
1 Year
+12.4%
+12.4%
More News
Read More
3 Stocks to Buy and Hold for 2026 and Beyond
↗
February 19, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
2 Dividend Stocks to Hold for the Next 5 Years
↗
February 19, 2026
Via
The Motley Fool
Topics
Energy
Intellectual Property
What's going on in today's session: S&P500 movers
↗
February 18, 2026
Via
Chartmill
6 Forever Dividend Stocks
↗
February 18, 2026
Via
The Motley Fool
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid
February 17, 2026
Via
StockStory
8 Cheap Stocks to Buy in 2026
↗
February 16, 2026
Via
The Motley Fool
1 No-Brainer Dividend Stock to Buy on the Dip
↗
February 15, 2026
Via
The Motley Fool
Topics
Intellectual Property
5 Best Stocks to Buy in February
↗
February 15, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
3 Dividend Stocks to Hold for the Next 20 Years
↗
February 15, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
↗
February 14, 2026
Via
The Motley Fool
Topics
Stocks
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
↗
February 14, 2026
Via
The Motley Fool
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Government
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
1 Reason I'm Never Selling AbbVie Stock
↗
February 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
February 11, 2026
Via
Finterra
Topics
Economy
Intellectual Property
The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call
February 11, 2026
Via
StockStory
Topics
Earnings
Silver and Gold Prices Are Volatile. Buy This ETF for Safety This Year
↗
February 10, 2026
Via
The Motley Fool
Topics
ETFs
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
February 10, 2026
Via
FinancialNewsMedia
3 Market-Beating Stocks to Research Further
February 08, 2026
Via
StockStory
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal
↗
February 05, 2026
Via
MarketBeat
ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds
February 05, 2026
Via
StockStory
AbbVie (ABBV) Q4 2025 Earnings Call Transcript
↗
February 04, 2026
Via
The Motley Fool
Topics
Earnings
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 229.48
When was AbbVie last traded?
The last trade of AbbVie was at 02/23/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.